Advertisement

Evaluation and Management of the Euthyroid Nodular and Diffuse Goiter

  • Peter A. Singer
Part of the Contemporary Endocrinology book series (COE, volume 2)

Abstract

Palpable thyroid nodules among adult individuals living in the United States are very common, with a prevalence of approx 4–7% (1). By contrast, the prevalence of nodules incidentally detected at autopsy, or by the use of high resolution ultrasonography, has ranged from approx 20 to 65% in individuals without a prior history of thyroid disease (26). Thyroid nodules are more common in women, estimates varying from a female-to-male ratio of 1.2:1 (2,7) to 4.3:1 (8) and increase in prevalence with advancing age (9,10). The likelihood of a single palpable thyroid nodule being malignant is less than 10%, and possibly closer to 5% (1,10,11). Nevertheless, because of the possibility of cancer, some clinicians, especially those in the surgical subspecialties, recommend that all nodules be removed. Other physicians, especially endocrinologists, recommend a more conservative approach in order to avoid unnecessary surgery. Thus, there is an ongoing debate regarding the appropriate evaluation and management of individuals with thyroid nodules. The main purpose of this article is to address these issues and to provide a clinically applicable and cost-effective approach to the evaluation and management of nodular thyroid disease. There are several excellent reviews to which the reader is directed (1,9,10,12–15).

Keywords

Thyroid Cancer Thyroid Nodule Papillary Thyroid Cancer Medullary Thyroid Cancer Multinodular Goiter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553–559.PubMedGoogle Scholar
  2. 2.
    Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocriol Metab 1955; 15: 1270–1280.Google Scholar
  3. 3.
    Rice CO. Incidence of nodules in the thyroid: a comparative study of symptomless thyroid glands removed at autopsy and hyperfunctioing goiters operatively removed. Arch Surg 1932; 24: 505–515.Google Scholar
  4. 4.
    Brander A, Viikinkoski P, Nickels J, Kivisaari. L. Thyroid gland: US screening in a random adult population. Radiology 1991; 181: 683–687.PubMedGoogle Scholar
  5. 5.
    Bruneton JN, Balu-Maestro C. Marcy PY, Melia PY, Mourou MY. Very high frequency (13 MHz) ultrasonographic examination of the normal neck, detection of normal lymph nodes and thyroid nodules. J Ultrasound Med 1994; 13: 87–89.PubMedGoogle Scholar
  6. 6.
    Ezzat S, Sarti DA, Cain Dr, Braunstein GD. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Intern Med 1994; 154: 1838–1840.PubMedGoogle Scholar
  7. 7.
    Ozdemir H, Ilgit ET, Yucel C, Atilla S, Isik S, Cakir N, et al. Treatment of autonomous thyroid nodules: safety and efficacy of sonographically guided percutaneous injection of ethanol. Am J Roentgeno11994; 163: 929–932.Google Scholar
  8. 8.
    Thomas CG, Buckwalter JA, Staab EV, Kerr CY. Evaluation of dominant thyroid masses. Ann Surg 1976; 183: 463–469.PubMedGoogle Scholar
  9. 9.
    Mazzaferri EL, de los Santos ET, Rofagha-Keyhani S. Solitary thyroid nodule: diagnosis and management. Med Clin N Am 1988; 72: 1177–1211.PubMedGoogle Scholar
  10. 10.
    Rojeski MT, Gharib H. Nodular thyroid disease: evaluation and management. N Engl J Med 1985; 313: 428–436.PubMedGoogle Scholar
  11. 11.
    Belfiore A, LaRosa GL, LaPorta GA. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992; 93: 363–369.PubMedGoogle Scholar
  12. 12.
    Molitch M, Beck JR, Dreisman M, Gottlieb JE, Pauker SG. The cold thyroid nodule: an analysis of diagnostic and therapeutic options. Endo Rev 1984; 5: 185–199.Google Scholar
  13. 13.
    Ridgway EC. Clinician’s evaluation of a solitary thyroid nodule. J Clin Endocrinol Metab 1992; 74: 231–235.PubMedGoogle Scholar
  14. 14.
    Guiffrida D, Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 1995; 99: 642–650.Google Scholar
  15. 15.
    Burch HB. Evaluation and management of the solid thyroid nodule. Endocrinol Metab Clin N Am 1995; 24: 663–710.Google Scholar
  16. 16.
    Cerise EJ, Randall S, Oschner A. Carcinoma of the thyroid and nontoxic nodular goiter. Surgery 1952; 31: 552–561.PubMedGoogle Scholar
  17. 17.
    Hamming JF, Goslings BM, van Steenis GJ, Claasen HV, Hermans J, van de Velde CJH. The value of fine needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med 1990; 150: 113–116.PubMedGoogle Scholar
  18. 18.
    Layfield LJ, Reichman A, Bottles K, Giuliano A. Clinical determinants for the management of thyroid nodules by fine needle aspiration cytology. Arch Otolaryngol Head Neck Surg 1992; 118: 717–721.PubMedGoogle Scholar
  19. 19.
    Schneider AB, Bekerman C Favus M, Frohmann LA, Gonzalez C, Ryo UY, et al. Continuing occurrences of thyroid nodules after head and neck irradiation: relation to plasma thyroglobulin concentrations. Ann Intern Med 1981; 94: 176–180.PubMedGoogle Scholar
  20. 20.
    Schneider AB. Radiation-induced thyroid tumors. Endocrinol Metab Clin N Am 1990; 19: 495–508.Google Scholar
  21. 21.
    Lairmore TC, Wells SA. Medullary carcinoma of the thyroid: current diagnosis and management. Sem Surg Oncol 1991; 7: 92–99.Google Scholar
  22. 22.
    Hrafnkelsson J, Tulinius H, Jonasson JG, Olafsdottir G, Sigvaldason H. Papillary thyroid carcinoma in Iceland: a study of the occurrence in families and the co-existence of other primary tumours. Acta Oncol 1989; 28: 785–788.PubMedGoogle Scholar
  23. 23.
    Gorlin JB, Sallan SE. Thyroid cancer in childhood. Endocrinol Metab Clin North Am 1990; 19: 649–662.PubMedGoogle Scholar
  24. 24.
    McHenry C, Smith M, Lawrence AM, Jarosz H, Paloyan E. Nodular thyroid disease in children and adolescents: a higher incidence of carcinoma. Am Surg 1988; 54: 444–447.PubMedGoogle Scholar
  25. 25.
    Belfiore A, Giuffrida D, La Rosa GL, Ippolito O, Russo G, Fiumara A, et al. High frequency of cancer in cold thyroid nodules occurring at a young age. Acta Endocrinol (Copenh) 1989; 121: 197–202.Google Scholar
  26. 26.
    Singer PA. Thyroiditis: acute, subacute, and chronic. Med Clin N Am 1991; 75: 61–77.PubMedGoogle Scholar
  27. 27.
    Hamburger JI. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab 1980; 50: 1089–1093.PubMedGoogle Scholar
  28. 28.
    Mazzaferri EI, Young RI, Oertel JE, Kemmeres WT, Page CP. Papillary thyroid cancer: the impact of therapy in 576 patients. Medicine 1977; 56: 171–196.PubMedGoogle Scholar
  29. 29.
    McConahey WM, Hay ID, Woolner LB, Van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, and outcome. Mayo Clin Proc 1986; 61: 978–996.PubMedGoogle Scholar
  30. 30.
    Schimke RN, Hartmann WH, Prout TE, Rimoin DL. Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas: a possible regulatory defect in the differentiation of chromaffin tissue. N Engl J Med 1968; 279: 1–7.PubMedGoogle Scholar
  31. 31.
    McCall A, Jarosz H, Lawrence AM, Paloyan E. The incidence of thyroid carcinoma in solitary cold nodules and in multinodular goiters. Surgery 1986; 100: 1128–1132.PubMedGoogle Scholar
  32. 32.
    Anglem TJ, Bradford ML. Nodular goiter and thyroid cancer. N Engl J Med 1948; 239: 217–220.PubMedGoogle Scholar
  33. 32a.
    Singer PA. Evaluation and management of the solitary thyroid nodule. Otolaryngol Clin N Am 1996; 29: 577–591.Google Scholar
  34. 33.
    Bastenie PA, Bonnyns M, VanHaelst L. Natural history of primary myxedema. Am J Med 1985; 79: 91–100.PubMedGoogle Scholar
  35. 34.
    Beever K, Bradbury J, Phillips D, McLachlan SM, Pegg C, Goral A, et al. Highly sensitive assays of autoantibodies in thyroglobulin and thyroid peroxidase. Clin Chem 1989; 35: 1949–1954.PubMedGoogle Scholar
  36. 35.
    Van Herle AJ, Uller RP, Matthews NL, Brown J. Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest 1973; 52: 1320–1327.PubMedGoogle Scholar
  37. 36.
    Christensen SB, Bondeson L, Ericsson UB, Lindholm K. Prediciton of malignancy in the solitary thyroid nodule by physical examination, thyroid scan, fine needle biopsy and serum thyroglobulin. Acta Chir Scand 1984; 150: 433–439.PubMedGoogle Scholar
  38. 37.
    Melvin KEW, Miller HH, Tashijian AH. Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. N Engl J Med 1971; 285: 1115–1120.PubMedGoogle Scholar
  39. 38.
    Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, DiCoscio G, et al. Routine measurement of serum calcitonin in nodule thyroid disease allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 1994; 78: 826–991.PubMedGoogle Scholar
  40. 39.
    Dunn JT. When is a thyroid nodule a sporadic medullary carcinoma (editorial). J Clin Endocrinol Metab 1994; 78: 824–825.PubMedGoogle Scholar
  41. 40.
    Caruso D, Mazzaferri EL. Fine needle aspiration biopsy in the management of thyroid nodules. The Endocrinologist 1991; 1: 194–202.Google Scholar
  42. 41.
    Van Herle AJ, Rick P, Ljung BME, Ashcraft MW, Solomon DH, Keeler ER. The thyroid nodule. Ann Intern Med 1982; 96: 221–232.Google Scholar
  43. 42.
    Cavalieri RR. Thyroid radioiodine uptake: indication and interpretations. The Endocrinologist 1992; 2: 341–347.Google Scholar
  44. 43.
    Ashcraft, MW, Van Herle AJ. Management of thyroid nodules, I. History and physical examination, blood tests, x-ray tests, and ultrasonography. Head Neck Surg 1981; 3: 216–230.PubMedGoogle Scholar
  45. 44.
    Vander JB, Gaston EA, Dawber TR. The significant of nontoxic thyroid nodules: final report of a 15 year study of the incidence of thyroid malignancy. Ann Intern Med 1968; 69: 537–540.PubMedGoogle Scholar
  46. 45.
    Ashcraft MW, Van Herle AJ. Management of thyroid nodules II: Scanning techniques, thyroid suppressive therapy, and fine needle aspiration. Head Neck Surg 1981; 3: 297–322.PubMedGoogle Scholar
  47. 46.
    de los Santos ET, Rofagha-Keyhani S, Cunningham JJ, Mazzaferri E. Cystic thyroid nodules: the dilemma of malignant lesions. Arch Intern Med 1990; 150: 1422–1427.PubMedGoogle Scholar
  48. 47.
    Simeone JF, Daniels GH, Mueller PR, Maloof F, vanSonnenberg E, Hall DA, et al. High resolution real time sonography of the thyroid. Radiology 1982; 145: 431–435.PubMedGoogle Scholar
  49. 48.
    Solbiati L, Volterrani L, Rizzato G, Bazzochi M, Busilaca P, Candian F, et al. The thyroid gland with low uptake lesions: evaluation by ultrasound. Radiology 1985; 155: 187–191.PubMedGoogle Scholar
  50. 49.
    Cochand-Priollet B, Guillausseau P, Chagnon S, Hoang C, Guillausseau-Scholar C, Chanson P, et al. The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctioning thyroid nodules: a prospective study comparing cytologic and histologic findings. Am J Med 1994; 97: 152–157.PubMedGoogle Scholar
  51. 50.
    Van Der Shaar H, Mulder H. Lesions of the thyroid gland in patients with primary hyperparathyroidism. Surg Gynecol Obstet 1985; 160: 407, 408.Google Scholar
  52. 51.
    Hurley DL, Gharib H. Evaluation and management of multinodular goiter. Otolaryngol Clin N Am 1996; 29: 527–540.Google Scholar
  53. 52.
    Russell P. Lean CI, Delbridge L, May GL, Dowd S, Mountford CE. Proton magnetic resonance and human thyroid neoplasia I: discriminiation between benign and malignant neoplasms. Am J Med 1994; 96: 383–388.PubMedGoogle Scholar
  54. 53.
    Campbell JP, Pillsbury HC. Management of the thyroid nodule. Head Neck 1989; 11: 414–425.PubMedGoogle Scholar
  55. 54.
    Caplan RH, Kisken WA, Strutt PJ, Wester SM. Fine needle aspiration biopsy of thyroid nodules: a cost effective diagnosis plan. Postgrad Med 1991; 90: 183–190.PubMedGoogle Scholar
  56. 55.
    Cole WH, Majarakis JD, Slaughter DP. Incidence of carcinoma of the thyoird in nodular goiter. J Clin Endocrinol and Metab 1949; 9: 1007–1011.Google Scholar
  57. 56.
    Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc 1994; 69: 44–49.PubMedGoogle Scholar
  58. 57.
    Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 1993; 118: 282–289.PubMedGoogle Scholar
  59. 58.
    Hamburger JI. Diagnosis of thyroid nodules by fine needle biopsy: use and abuse. J Clin Endocrinol Metab 1994; 79: 335–339.PubMedGoogle Scholar
  60. 59.
    Solomon D. Fine needle aspiration of the thyroid: an update. Thyroid Today 1993; 16: 1–9.Google Scholar
  61. 60.
    Tani E. Lambert S. Fine needle aspiration cytology and immunocytochemistry in the diagnosis of lymphoid lesions of the thyroid gland. Acta Cytol 1989; 33 (1): 48–52.PubMedGoogle Scholar
  62. 61.
    Silverman JF, Khazanie PG, Norris HT, Fore WW. Parathyroid hormone (PTH) assay of parathyroid cysts examined by fine needle aspiration biospy. Am J Clin Pathol 1986; 86 (6): 776–780.PubMedGoogle Scholar
  63. 62.
    Busseniers AE, Oetel YCL. Cellular adenomatoid nodules of the thyroid: review of 219 fine needle aspirates. Diagn Cytopathol 1993; 9: 581–589.PubMedGoogle Scholar
  64. 63.
    Cersosimo E, Gharib H, Suman VJ, Goellner JR. “Suspicious” thyroid cytologic findings: outcome in patients without immediate surgical treatment. Mayo Clin Proc 1993; 68: 343–348.PubMedGoogle Scholar
  65. 64.
    Gharib H, Goellner JR, Zinsmeiseter AR, Grant CS, Van Heerden JA. Fine-needle aspiration biopsy of the thyroid. Ann Intern Med 1984; 101: 25–28.PubMedGoogle Scholar
  66. 65.
    Miller JM, Kini SR, Hamburger JI. The diagnosis of malignant follicular neoplasms of the thyroid by needle biopsy. Cancer 1985; 55: 2812–2817.PubMedGoogle Scholar
  67. 66.
    Altavilla G, Pascale M, Nenci I. Fine needle aspiration cytology of thyroid gland disease. Acta Cytol 1990; 34: 251–256.PubMedGoogle Scholar
  68. 67.
    Gharib H, Goellner JR, Johnson DA. Fine needle aspiration cytology of the thyroid: a 12 year experience with 11,000 biopsies. Clin Lab Med 1993; 13: 699–709.PubMedGoogle Scholar
  69. 68.
    Mazzaferri EL. Thyroid cancer in thyroid nodules: finding a needle in a haystack. Am J Med 1992; 93: 359–362.PubMedGoogle Scholar
  70. 69.
    Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol 1987; 31: 587–590.Google Scholar
  71. 70.
    Hall TL, Layfield LJ, Philippe A, Rosenthal DL. Sources of diagnostic error in fine needle aspiration of the thyroid. Cancer 1989; 63: 718–725.PubMedGoogle Scholar
  72. 71.
    Hales MS, Hsu FSF. Needle tract implantation of papillary carcinoma of the thyroid following aspiration biopsy. Acta Cytol 1990; 34: 801–804.PubMedGoogle Scholar
  73. 72.
    Hamberger B, Gharib H, Melont LJ, Goellner JR, Zinsmeister AR. Fine needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med 1983; 73: 381–384.Google Scholar
  74. 73.
    Bistrup C. Nielsen JD, Gregersen G, Franch P. Preventive effect of levothyroxine in patients operated for nontoxic goiter: a randomized trial of one hundred patients with nine years of follow up. Clin Endocrinol 1994; 40: 323–327.Google Scholar
  75. 74.
    Cooper DS. Thyroxine suppression therapy for benign nodular disease. J Clin Endocrinol Metab 1995; 80: 331–334.PubMedGoogle Scholar
  76. 75.
    Hegedus L, Hansen JM, Veiergang D, Karstrup S. Does prophylactic thyroxine treatment after operation for nontoxic goiter influence thyroid size? Br Med J 1987; 294: 801–803.Google Scholar
  77. 76.
    Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, Stevens W. Natural history of thyroid abnormalities, prevalence, incidence, and regression of thyroid disease in adolescents and young adults. Am J Med 1991; 91: 363–370.PubMedGoogle Scholar
  78. 77.
    Fogelfeld L, Wiviott MBT, Shore-Freedman E, Blend M, Bekerman C, Pinksy S, et al. Recurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions. N Engl J Med 1989; 320: 835–840.PubMedGoogle Scholar
  79. 78.
    Ross DS. Subclinical hyperthyroidism: possible danger of overzealous thyroxine replacement therapy. Mayo Clin Proc 1988; 63: 1223–1229.PubMedGoogle Scholar
  80. 79.
    Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary thyroid axis with L-thyroxine. Am J Med 1987; 82: 1167–1170.PubMedGoogle Scholar
  81. 80.
    Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A. Carefully monitored levothy-roxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 1994; 78: 818–823.PubMedGoogle Scholar
  82. 81.
    Franklyn JA, Betteridge J, Daykin J, Holder R, Oates GD, Parle JV, et al. Long-term thyroxine treatment and bone mineral density. Lancet 1992; 340: 9–13.PubMedGoogle Scholar
  83. 82.
    Cooper DS. Thyroid hormone, osteoporosis, and estrogen. JAMA 1994; 271: 1245–1249.Google Scholar
  84. 83.
    Schneider DL, Barrett-Conner EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly women. JAMA 1994; 271: 1245–1249.Google Scholar
  85. 84.
    Biondi B, Fazio S, Carella C, Amato G, Cittadini A, Lupoli G, et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1993; 77: 334–338.PubMedGoogle Scholar
  86. 85.
    Sawin CT, Geller A. Wolfe PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249–1252.PubMedGoogle Scholar
  87. 86.
    Gharib H, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study. N Engl J Med 1987; 316: 764–770.Google Scholar
  88. 87.
    Reverter JL, Lucas A, Salinas I, et al. Suppressive therapy with levothyroxine for solitary thyroid nodules. Clin Endocr 1992; 36: 25–28.PubMedGoogle Scholar
  89. 88.
    Celani MF, Mariani M, Mariani G. On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominately solid thyroid nodules. Acta Endocrinol 1990; 123: 603–608.PubMedGoogle Scholar
  90. 89.
    Cheung PSY, Lee JMH, Boey JH. Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 1989; 13: 818–822.PubMedGoogle Scholar
  91. 90.
    LaRosa GL, Lupo L, Guiffrida D, Gullo D, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 1995; 122: 1–8.Google Scholar
  92. 91.
    Morita T. Tamai H, Oshima A, Komaki G, Matsubayashi S, Kuma K, et al. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules. J Clin Endocrinol Metab 1989; 69: 227–230.PubMedGoogle Scholar
  93. 92.
    Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 1990; 89: 602–608.PubMedGoogle Scholar
  94. 93.
    Studer H. Gerber H. Multinodular goiter. In: DeGroot L, ed. Endocrinology 3rd ed. WB Saunders, Philadelphia, 1995, pp. 769–782.Google Scholar
  95. 94.
    Benua RS, Cicale NR, Sonenberg M, et al. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Radiol 1962; 87: 171–182.Google Scholar
  96. 95.
    Kraimps JL, Marechaud R, Gineste D, Fieuzal S, Metaye T, Carretier M, et al. Analysis and prevention of recurrent goiter. Surg Gynecol Obstet 1993; 176: 319–3322.PubMedGoogle Scholar
  97. 96.
    Geerdsen JP, Frolund L. Recurrence of nontoxic goiter goiter with and without postoperative thyroxine medication. Clin Endocrinol (Oxf) 1984; 21: 529–533.Google Scholar
  98. 97.
    Celani MF. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter. Exp Clin Endocrinol 1993; 101: 326–332.PubMedGoogle Scholar
  99. 98.
    Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL.Comparision of placebo with L-thyroxine alone or with carbimozole for treatment of sporadic nontoxic goiter. Lancet 1990; 336: 193–197.PubMedGoogle Scholar
  100. 99.
    Rieu M, Bekka S, Sambor B, et al. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with nontoxic nodular goiter. Clin Endocrinol 1993; 39: 67–71.Google Scholar
  101. 100.
    Edmonds C. Treatment of sporadic goitre with thyroxine. Clin Endocrinol (Oxf) 1992; 36: 21–23.Google Scholar
  102. 101.
    Kay TW, d’Emden MC, Andrews JT, Martin FIR. Treatment of nontoxic multinodular goiter with radioactive iodine. Am J Med 1988; 84: 19–22.PubMedGoogle Scholar
  103. 102.
    Nygaard B, Hegedus L, Gervil M, Hjalgrim H, Se-Jensen P, Hansen JM. Radioiodine treatment of multinodular non-toxic goiter. Brit Med J 1993; 307: 828–832.PubMedGoogle Scholar
  104. 103.
    Huysmans DAKC, Hermus ARMM, Frans HM, Corstens MD, Barentsz JO, Kloppeborg WC. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994; 121: 757–762.PubMedGoogle Scholar
  105. 104.
    Meier CA, Braverman LE, Ebner SA, Veronikis I, Daniels GH, Ross DS, et al. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I/II Study). J Clin Endocrinol Metab 1994; 78: 188–196.PubMedGoogle Scholar
  106. 105.
    DeGroot LJ. Diagnostic approach and management of patients exposed to irradiation to the thyroid. J Clin Endocrinol Metab 1989; 69: 925–928.PubMedGoogle Scholar
  107. 106.
    Schneider AB, Ron E, Lubin J, Stoval M, Gierlowski TC. Dose-response relationships for radiation induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 1993; 77: 362–369.PubMedGoogle Scholar
  108. 107.
    DeGroot LJ, Reilly M, Pinnameneni K, Refetoff S. Retrospective and prospective study of radiation-induced thyroid disease. Am J Med 1983; 74; 852–862.PubMedGoogle Scholar
  109. 108.
    Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, et al: Treatment guidelines for patients with thyroid nodules and well differentiated thyroid cancer. Arch Int Med 1996, in press.Google Scholar
  110. 109.
    Doherty CM, Shindo ML, Rice DH, Montoro M, Mestman JH. Manangement of thyroid nodules during pregnancy. Laryngoscope 1995; 105: 251–255.PubMedGoogle Scholar
  111. 110.
    Rose IB, Walfish PG. Pregnancy as a predisposing factor in thyroid neoplasia. Arch Surg 1986; 121: 1287–1291.Google Scholar
  112. 111.
    Studer H, Gebel F. Simple and nodule sporadic goiter. In: Ingbar SH, Braverman LE, eds. The Thyroid 6th ed. Lippincott, Philadelphia, 1991, pp. 698–704.Google Scholar
  113. 112.
    Van der Gaag RD, Dreshage HA, Wiersinga, Brown RS, Doctor R, Bottazo GF, et al. Further studies on thyroid growth stimulating immunoglobulins in euthyroid nonendemic goiter. J Clin Endocrinol Metab 1985; 60: 972–979.PubMedGoogle Scholar
  114. 113.
    Studer H, Ramelli F. Simple goiter and its variants: euthyroid and hyperthyroid multinodular goiters. Endocr Rev 1982: 40–61.Google Scholar
  115. 114.
    Studer H, Gerber H. Clinical manifestations and management of nontoxic diffuse and nodular goiter. In: Ingbar SH, Braverman LE, eds. The Thyroid 6th ed. Lippincott, Philadelphia, 1991, pp. 1114–1118.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Peter A. Singer

There are no affiliations available

Personalised recommendations